SCHEMBL3971384

SCHEMBL3971384

c1cc2c3c(ccc2cn1)OCO3

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
LMNA P02545 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 3/20 0.43
MAPK1 P28482 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RGS17 Q9UGC6 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
GMNN O75496 1/20 0.43
POLB P06746 1/20 0.43
BLM P54132 1/20 0.43
CDC42 P60953 1/20 0.43
RAC1 P63000 1/20 0.43
PMP22 Q01453 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP3A4 P08684 3/20 0.41
ACHE P22303 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968484 0.86 IDO1 (0.44) KDM4ELMNACYP3A4ACHEHTT
SCHEMBL8072960 0.78 SMN1; SMN2 (0.43) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL403982 0.73 BAD (0.49) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL30400843 0.73 BAD (0.49) KDM4ELMNAALDH1A1MAPTHPGD
SCHEMBL3672089 0.73 AOC3 (0.44) KDM4ELMNAALDH1A1MEN1KMT2A
SCHEMBL30466406 0.71 GAA (0.46) KDM4ELMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL1201537 0.71 GAA (0.46) KDM4ELMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL445595 0.71 IMPDH2 (0.58) KDM4ELMNAALDH1A1HPGDMAPK1
SCHEMBL8274137 0.70 IDO1 (0.40) KDM4ELMNAHPGDCYP3A4ACHE
SCHEMBL8274136 0.70 IMPDH2 (0.39) KDM4ELMNACYP3A4ACHEHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
WO-2006000085-A1 HEPATITIS C INHIBITOR PEPTIDE ANALOGS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179151-A1 Isoquinoline aminopyrazole derivatives CYP3A5, CYP3A43, CYP3A4 KDM4E 2767/4885LMNA 2269/4885ALDH1A1 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.